Doctors Warn Of Malaria Drug Scarcity
Faizan Hashmi Published April 02, 2020 | 05:09 PM
Limited global stocks of two anti-malarial drugs could wreck plans to use the medicines, currently in clinical trials, to treat COVID-19, doctors cautioned on Thursday
Paris, (UrduPoint / Pakistan Point News - 2nd Apr, 2020 ) :Limited global stocks of two anti-malarial drugs could wreck plans to use the medicines, currently in clinical trials, to treat COVID-19, doctors cautioned on Thursday.
Around the world, countries are expanding access to chloroquine (CQ) and hydroxychloroquine (HCQ), which are used to treat malaria and are known to have anti-viral properties.
The medicines have shown early promise against the COVID-19 illness in studies in France and China.
CQ, which is the less toxic of the two, is also used as an anti-inflammatory to treat conditions like rheumatoid arthritis and lupus, purposes it is primarily known for outside the tropics.
Writing in the Annals of Rheumatic Diseases, doctors in Italy -- the country hardest hit by COVID-19 -- said that limited supply could scupper any widespread attempt to use the two drugs against the virus.
They also cautioned that it was vital that patients already taking chloroquine for other illnesses should not be deprived of their supply.
"In some European countries the availability of HCQ and CQ in the pharmacies (outside the hospitals) is already scarce," Francesca Romana Spinelli, assistant professor at the Sapienza University of Rome and letter author, told AFP.
"This is an emerging problem for many patients already treated with CQ/HCQ for their autoimmune rheumatic disease.
" Both medicines are known to have anti-viral properties and have shown some encouraging results in trials against COVID-19.
But they have a number of potentially serious side effects, and there are fears that treating COVID-19 patients, many of whom are on medication for underlying conditions, could court disaster.
On Wednesday the European Medicine Agency warned that CQ and HCQ should only be used on COVID-19 patients in clinical trials or in case of a "national emergency".
Iain McInnes, president of the European League Against Rheumatism (EULAR), said that more research was needed before governments could consider rolling out the two drugs against the virus.
He said he was concerned "that the diversion of drug supplies away from people with rheumatic and musculoskeletal diseases may compromise the health of this important and sizable group of patients in Europe and beyond."In the letter, Italian doctors said using CQ and HCQ as widespread COVID-19 treatments would raise ethical concerns, given their known side effects.
"If mass prophylaxis was accepted as an option worldwide, this would raise the question of whether there is enough supply of chloroquine and hydroxychloroquine to support this approach," they added.
Recent Stories
HEC reviews curricula for environmental sciences degree programme
ICC Asia looking forward to an action-packed Asia Cricket Week
Yuvraj Singh named ICC Men’s T20 World Cup 2024 Ambassador
Greece hands Olympic flame to 2024 Paris Games hosts
Two Kyiv hospitals evacuating over feared Russian strikes
World must act on neurotech revolution, say experts
Charles & Catherine's cancer diagnoses
Champions Alcaraz and Sabalenka through in Madrid Open
King Charles to resume some public duties during cancer treatment: palace
US defense chief announces $6 bn in security aid for Ukraine
Heavy rains cause damage to Spezand-Taftan railway track
Woman stabbed in Israel, attacker killed: police
More Stories From Health
-
Vaccines save at least 154 million lives in 50 years: WHO
3 days ago -
UHS to issue MBBS degrees within three months after final result
3 days ago -
Rawalpindi woman gives birth to six babies
8 days ago -
DC calls for intensive anti-polio drive in ICT
9 days ago -
World Hemophilia Day observed to underscore importance of providing comprehensive care
9 days ago -
Six in a family with heart on the 'right side'
9 days ago
-
Diabetic disease increasing rapidly : Dr. Noor Elahi Memon
10 days ago -
World Hemophilia Day observed
10 days ago -
ATC dismisses bail petition of doctor involved in illegal kidneys transplant
17 days ago -
Dr. Shehzad warns against deviation from WHO guidelines on anti-smoking
18 days ago -
Health activists express concerns over attempts to derail tobacco control
20 days ago -
UHS declares MBBS first prof, MS urology exam results
29 days ago